118 publications

Name Date Type Actions

Monthly information regarding the total number of voting rights and shares making of the share capital - August 2021

 		06/09/2021

Monthly information regarding the total number of voting rights and shares making of the share capital - May 2021

 		04/06/2021

Programme de rachat - June 2021

 		05/07/2021

2024 Calendar of financial communication

Vetoquinol published its calendar of financial communication for 2024.

 		03/01/2024 Agenda

2022 Calendar of financial communication

Vetoquinol published its calendar of financial communication for 2022.

 		17/12/2021 Agenda

Financial statements 2012

1.1CONSOLIDATED FINANCIAL STATEMENTS p.4

 		30/04/2013 Annual Report

2012 ANNUAL RESULTS

SFAF Meeting March 27, 2013

 		28/03/2013 Annual Report

Vétoquinol : 80 years striving for animal health worldwide

Founded in 1933, Vétoquinol is now a leading global animal health company.
The number 10 global animal health company and the third
largest in France, the Vétoquinol Group combines sustainability,
growth and independence in an increasingly competitive world
market.
Committed to the protection and well-being of both animals
and people, Vétoquinol creates, develops and sells veterinary
drugs and non-medical products all over the world.
The company is widely reputed for its expertise in the fields of infectious diseases, pain and inflammation in livestock (cattle and pigs) and pets (dogs and cats).
For over 80 years, Vétoquinol's pursuit of growth has been underpinned by strong values of team spirit, performance and the sharing of corporate culture and know-how with customers, vets, breeders, partners and employees alike.

 		17/05/2013 Annual Report

[VIDEO ]Présentation des résultats 2020 - french

Présentation analystes & investisseurs - 1er avril 2021

 		01/04/2021 Annual Report

ANNUAL RESULTS 2023 (slideshow)

01.2023 Highlights
02.2023 Consolidated financial statements
03.Strategy and outlook

 		20/03/2024 Annual Report